Get the Stockscreener App
0.5034
0.68%
0.0034
After Hours:
.50
-0.0034
-0.68%
Fibrogen Inc Stock (FGEN) Forecast
The Fibrogen Inc (FGEN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.22, representing a +2,526% increase from the current price of $0.5034. The highest analyst price target is $17.00, and the lowest is $9.4394.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FGEN Price Target
Average 13.18
(+2,519% Upside)
Is Fibrogen Inc (FGEN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.12 | Neutral |
| STOCH(9,6) | 42.06 | Neutral |
| STOCHRSI(14) | 84.98 | Sell |
| MACD(12,26) | -0.00233 | Sell |
| ADX(14) | 17.25 | Neutral |
| William %R | -55.50 | Neutral |
| CCI(14) | 8.7187 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4893
Buy
|
0.4988
Buy
|
| MA20 |
0.5227
Sell
|
0.5057
Sell
|
| MA50 |
0.4754
Buy
|
0.4837
Buy
|
| MA100 |
0.4173
Buy
|
0.5012
Buy
|
| MA200 |
0.6499
Sell
|
0.6256
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, FGEN could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on FGEN, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.12 indicates that FGEN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 42.06 indicates that FGEN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 84.98 indicates that FGEN is oversold. This suggests that FGEN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 8.7187 indicates that FGEN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FGEN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fibrogen Inc financial reports and earnings history, Fibrogen Inc (FGEN) stock could reach $32.28 by 2030, $6.0268 by 2040 and $65.93 by 2050. See the projected annual prices until 2050 of the Fibrogen Inc stock below:
- Fibrogen Inc (FGEN) is expected to reach an average price of $8.1688 in 2035, with a high prediction of $8.999 and a low estimate of $8.1838. This indicates an $1,523% rise from the last recorded price of $0.5034.
- Fibrogen Inc (FGEN) stock is projected to chart a bullish course in 2040, with an average price target of $7.4998, representing an $1,390% surge from its current level. The forecast ranges from a conservative $5.2621 to a sky-high $6.0268.
- Our analysts predict Fibrogen Inc (FGEN) to jump 6,489% by 2045, soaring from $35.12 to an average price of $33.17, potentially reaching $36.25. While $35.12 is the low estimate, the potential upside is significant.
- Fibrogen Inc (FGEN) stock is expected to climb by 2050, reaching an average of $65.20, a $12,852% jump from its current level. However, a wide range of estimates exists, with high and low targets of $65.93 and $66.40, respectively, highlighting the market's uncertainty.
Fibrogen Inc Stock (FGEN) Year by Year Forecast
Fibrogen Inc Stock (FGEN) Price Forecast for 2025
Fibrogen Inc Stock (FGEN) is expected to reach an average price of $13.18 in 2025, with a high prediction of $25.67 and a low estimate of $0.7026. This indicates an +2,519% rise from the last recorded price of $0.5034.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $11.36 | $9.4394 | $17.00 | +2,156% |
| April, 2025 | $5.1946 | $0.7026 | $13.56 | +931.90% |
| May, 2025 | $10.26 | $2.9037 | $12.46 | +1,937% |
| June, 2025 | $8.1425 | $5.1483 | $12.96 | +1,517% |
| July, 2025 | $12.39 | $4.6289 | $13.77 | +2,362% |
| August, 2025 | $14.85 | $11.96 | $17.31 | +2,850% |
| September, 2025 | $17.74 | $13.44 | $21.54 | +3,423% |
| October, 2025 | $17.29 | $13.79 | $25.67 | +3,334% |
| November, 2025 | $15.68 | $15.50 | $20.31 | +3,015% |
| December, 2025 | $13.51 | $12.63 | $24.61 | +2,584% |
Fibrogen Inc Stock (FGEN) Price Forecast for 2026
The predicted value for Fibrogen Inc (FGEN) in 2026 is set at an average of $17.19. Estimates vary from a peak of $34.17 to a trough of $0.2131, indicating an +3,315% surge from the present price of $0.5034.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.76 | $12.94 | $19.93 | +3,031% |
| February, 2026 | $19.93 | $15.19 | $21.69 | +3,858% |
| March, 2026 | $19.73 | $13.13 | $20.86 | +3,820% |
| April, 2026 | $29.13 | $19.55 | $34.17 | +5,687% |
| May, 2026 | $11.65 | $9.5497 | $31.44 | +2,214% |
| June, 2026 | $3.4438 | $3.8938 | $14.05 | +584.12% |
| July, 2026 | $0.1167 | $0.4615 | $1.6885 | -76.82% |
| August, 2026 | $5.0731 | $0.2131 | $5.1021 | +907.77% |
| September, 2026 | $6.0537 | $3.7682 | $9.3663 | +1,103% |
| October, 2026 | $6.2399 | $6.9799 | $7.2478 | +1,140% |
| November, 2026 | $7.8734 | $7.7258 | $7.4234 | +1,464% |
| December, 2026 | $8.7129 | $7.6593 | $7.9829 | +1,631% |
Fibrogen Inc Stock (FGEN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fibrogen Inc (FGEN) is $4.3648, with a high forecast of $8.4188 and a low forecast of $0.3108. This indicates an +767.06% increase from the last price of $0.5034.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.6165 | $8.1865 | $8.4188 | +1,413% |
| February, 2027 | $5.81 | $6.1261 | $7.0523 | +1,054% |
| March, 2027 | $2.6795 | $4.4636 | $5.2218 | +432.27% |
| April, 2027 | $2.653 | $3.1813 | $2.493 | +427.02% |
| May, 2027 | $1.8566 | $2.3566 | $2.6889 | +268.81% |
| June, 2027 | $2.986 | $1.7084 | $2.066 | +493.18% |
| July, 2027 | $3.4896 | $3.1587 | $2.5396 | +593.21% |
| August, 2027 | $4.7932 | $3.2814 | $3.1032 | +852.16% |
| September, 2027 | $4.4326 | $5.6791 | $4.995 | +780.54% |
| October, 2027 | $4.0962 | $4.8203 | $4.3185 | +713.70% |
| November, 2027 | $1.2397 | $2.5697 | $2.1339 | +146.27% |
| December, 2027 | $1.4908 | $0.3108 | $1.6508 | +196.15% |
Fibrogen Inc Stock (FGEN) Price Forecast for 2028
In 2028, Fibrogen Inc (FGEN) is projected to reach an average price of $8.0652, with a high projection of $16.10 and a low estimate of $0.0263. This indicates an +1,502% rise from the last price of $0.5034.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0572 | $0.269 | $1.8849 | -88.63% |
| February, 2028 | $0.9237 | $0.0263 | $1.4637 | +83.49% |
| March, 2028 | $4.7642 | $0.7978 | $6.6801 | +846.41% |
| April, 2028 | $2.7907 | $1.9325 | $6.0833 | +454.36% |
| May, 2028 | $5.1212 | $2.8248 | $6.173 | +917.32% |
| June, 2028 | $9.9476 | $4.8053 | $11.15 | +1,876% |
| July, 2028 | $14.64 | $9.3718 | $16.10 | +2,809% |
| August, 2028 | $11.11 | $10.66 | $15.26 | +2,108% |
| September, 2028 | $11.04 | $9.2628 | $11.85 | +2,093% |
| October, 2028 | $9.3175 | $7.6834 | $12.58 | +1,751% |
| November, 2028 | $10.36 | $8.2616 | $11.62 | +1,958% |
| December, 2028 | $4.3655 | $4.6755 | $12.06 | +767.20% |
Fibrogen Inc Stock (FGEN) Price Forecast for 2029
The 2029 price forecast for Fibrogen Inc Stock (FGEN) is $10.13 on average, with a high prediction of $20.17 and a low estimate of $0.094. This represents an +1,913% increase from the previous price of $0.5034.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.435 | $4.2914 | $4.4591 | +781.00% |
| February, 2029 | $4.8285 | $4.5309 | $4.7526 | +859.18% |
| March, 2029 | $4.719 | $4.772 | $4.7253 | +837.42% |
| April, 2029 | $4.5306 | $4.5356 | $4.5481 | +800.01% |
| May, 2029 | $4.175 | $4.1591 | $4.3465 | +729.36% |
| June, 2029 | $3.4703 | $3.5487 | $3.866 | +589.36% |
| July, 2029 | $2.7559 | $2.8988 | $3.2999 | +447.46% |
| August, 2029 | $1.1517 | $2.1906 | $2.6102 | +128.78% |
| September, 2029 | $0.7952 | $0.7593 | $0.4676 | +57.97% |
| October, 2029 | $0.5353 | $0.094 | $0.6153 | +6.34% |
| November, 2029 | $0.4383 | $0.3694 | $0.8694 | -12.94% |
| December, 2029 | $33.51 | $0.1559 | $20.17 | +6,557% |
Fibrogen Inc Stock (FGEN) Price Forecast for 2030
Fibrogen Inc Stock (FGEN) is expected to reach an average price of $23.66 in 2030, with a high forecast of $32.28 and a low forecast of $15.04. This signifies an +4,600% surge from the last price of $0.5034.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.42 | $29.46 | $32.28 | +5,347% |
| February, 2030 | $21.65 | $23.82 | $22.66 | +4,200% |
| March, 2030 | $20.06 | $19.89 | $19.21 | +3,886% |
| April, 2030 | $21.10 | $21.64 | $20.00 | +4,092% |
| May, 2030 | $27.20 | $24.52 | $26.18 | +5,304% |
| June, 2030 | $23.91 | $24.71 | $26.05 | +4,649% |
| July, 2030 | $23.83 | $24.23 | $23.58 | +4,633% |
| August, 2030 | $15.75 | $15.04 | $17.86 | +3,028% |
| September, 2030 | $18.39 | $16.43 | $16.97 | +3,553% |
| October, 2030 | $13.56 | $15.75 | $17.22 | +2,593% |
| November, 2030 | $27.71 | $15.27 | $20.13 | +5,404% |
| December, 2030 | $25.48 | $25.84 | $28.40 | +4,962% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):